Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Clin Ther. 2019 Mar 28;41(4):656–674.e4. doi: 10.1016/j.clinthera.2019.03.002

Table 1.

A 2-way ANOVA of each measured variable as a function of condition (ME/CFS vs healthy control), timepoint, and interactions. Variables with at least one significant effect were constrained; others were left free.

Variable Condition Time Condition × Time Constrained (Y/N)
IL-lα 0.413 0.171 0.643 N
IL-1β 0.017 0.173 0.722 Y
IL-2 <0.001 0.523 0.899 Y
IL-4 <0.001 0.585 0.550 Y
IL-5 0.002 0.088 0.293 Y
IL-6 <0.001 0.433 0.035 Y
IL-8 0.481 0.760 0.869 N
IL-10 0.673 0.984 0.231 N
IL-12 0.825 0.588 0.580 N
IL-13 <0.001 0.403 0.009 Y
IL-15 0.041 0.337 0.343 Y
IL-17 0.257 0.802 0.627 N
IL-23 0.462 0.963 0.991 N
IFNγ 0.298 0.918 0.967 N
TNFα 0.584 0.244 0.894 N
B cell 0.672 0.369 0.991 N
NK cell <0.001 <0.001 0.285 Y